Re: “Dysautonomia in Childhood Cancer Survivors: A Widely Underestimated Risk” by Berger et al. ( J Adolesc Young Adult Oncol. 2019;8(1):9–17)

Berger C , Casagranda L , Pichot V , et al. Dysautonomia in childhood cancer survivors: a widely underestimated risk. J Adolesc Young Adult Oncol. 2018 [Epub ahead of print]; DOI: 10.1089/jayao.2018.0021.

Lipshultz SE , Cochran TR , Franco VI , Miller TL . Treatment-related cardiotoxicity in survivors of childhood cancer. Nat Rev Clin Oncol. 2013; 10(12):697–710.

Faber J , Wingerter A , Neu MA , et al. Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study. Eur Heart J. 2018; 39(17):1555–62.

Bloom MW , Hamo CE , Cardinale D , et al. Cancer therapy-related cardiac dysfunction and heart failure part 1: definitions, pathophysiology, risk factors, and imaging. Circ Heart Fail. 2016; 9(1):e002661.